1. TLE400 is an antiretroviral drug intended as a first-line treatment for HIV/AIDS patients in developing countries.
2. Xadago is an add-on treatment for patients with Parkinson’s disease who already take a combination therapy of levodopa and carbidopa for the condition, yet still experience “off” episodes.
3. Juvederm Vollure XC is a dermal filler used for the correction of moderate to severe facial wrinkles and folds.
4. The CoreValve Evolut Pro is a heart valve used for the treatment of severe aortic stenosis for patients with a high or extreme risk for open heart surgery.
More articles on supply chain:
Trump meets with Congressional Black Caucus, promises lower drug costs
Study: Surgeon scorecards reduce supply cost without affecting outcomes
FDA grants tentative approval to Mylan’s HIV/AIDS drug: 3 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.